Condition
SCLC,Extensive Stage clinical trials and research
As of November 12, 2026, Find a Trial lists 5 SCLC,Extensive Stage clinical trials that are recruiting, at sites in 16 countries (most in Italy (3), China (2), France (2)). By phase: Phase 2 (3), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 16Countries
Newest SCLC,Extensive Stage clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BL-M14D1 plus atezolizumab vs standard therapy in first-line extensive-stage small cell lung cancer | Phase 3 | Springdale, Arkansas and 61 other locations | Recruiting | Jun 4, 2026 |
| Adebrelimab plus etoposide capsules as maintenance therapy for extensive-stage small cell lung cancer | Phase 2 | Xi'an, Shannxi | Recruiting | Aug 26, 2025 |
| Hippocampal-sparing whole brain radiotherapy combined with stereotactic radiotherapy for extensive-stage small cell lung cancer with brain metastases | Phase 1/2 | Shanghai | Recruiting | Feb 5, 2024 |
| Niraparib with Anti-PD-L1 for SLFN11-positive Extensive-stage SCLC | Phase 2 | Angers and 17 other locations | Recruiting | Feb 8, 2023 |
| Treatment for Extensive Stage Small Cell Lung Cancer with Pembrolizumab and Olaparib | Phase 2 | Meldola, Forlì Cesena and 11 other locations | Recruiting | Nov 21, 2022 |
All recruiting trials (5)
-
BL-M14D1 plus atezolizumab vs standard therapy in first-line extensive-stage small cell lung cancer
A first-line treatment for adults with extensive-stage small cell lung cancer tests whether adding BL-M14D1 to atezolizumab and standard chemotherapy helps more than standard care.
-
Adebrelimab plus etoposide capsules as maintenance therapy for extensive-stage small cell lung cancer
This phase 2 trial will test whether adebrelimab combined with etoposide capsules as maintenance therapy helps people with extensive-stage small cell lung cancer who had no progression after initial platinum-based chemotherapy with adebrelimab.
-
Hippocampal-sparing whole brain radiotherapy combined with stereotactic radiotherapy for extensive-stage small cell lung cancer with brain metastases
This study is testing a new type of brain radiation treatment for people with extensive-stage small cell lung cancer that has spread to the brain, to see if it can help control their cancer while protecting their memory.
-
Niraparib with Anti-PD-L1 for SLFN11-positive Extensive-stage SCLC
This study is testing if adding a pill called niraparib to an existing treatment can help people with a specific type of advanced small cell lung cancer feel better after their initial therapy.
-
Treatment for Extensive Stage Small Cell Lung Cancer with Pembrolizumab and Olaparib
This study is testing a new treatment combining Pembrolizumab and Olaparib to see if it can help people with untreated extensive-stage small cell lung cancer live longer and feel better.
Related topics
Quick answers
How many SCLC,Extensive Stage clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in Italy (3 trials), China (2 trials), France (2 trials), Germany (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.